The Chemical Differences Between EPA and DHA.

Slides:



Advertisements
Similar presentations
Ronald A. Codario, MD Assistant Clinical Professor of Medicine
Advertisements

ATP III Guidelines Specific Dyslipidemias. 2 Specific Dyslipidemias: Very High LDL Cholesterol (  190 mg/dL) Causes and Diagnosis Genetic disorders –Monogenic.
METHODS A systematic review of evidence-based literature was performed using Medline and Cochrane databases. Studies reviewed include randomized controlled.
Lipid Disorders and Management in Diabetes
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Clinical Goals for the Healthy.
Chapter 5 The Lipids: Fats, Oils, Phospholipids, and Sterols
Addwell Omega 3.
Understanding blood lipids and glucose How a Healthy Lifestyle can improve your numbers Susan Fullmer, PhD RD Associate Teaching Professor Nutrition, Dietetics,
LDL Cholesterol Goals and Cutpoints for Therapeutic Lifestyle Changes (TLC) and Drug Therapy in Different Risk Categories Risk Category LDL Goal (mg/dL)
Frank A. Bucci, Jr., MD, Bucci Laser Vision Institute Wilkes Barre, PA Comparison of RBC Saturation with Omega- 3 Oral Supplements The author of this poster.
The Science of Plant Stanol Ester. Contents Background Plant stanol ester and LDL-cholesterol lowering Dose-response of plant stanol ester with high daily.
Metabolic Syndrome. America’s Health Status one-third of U.S. adults (35.7%) are obese. 17% (12.5 million) of children 2—19 years are obese. Top leading.
{ A Novel Tool for Cardiovascular Risk Screening in the Ambulatory Setting Guideline-Based CPRS Dialog Adam Simons MD.
Women and Cholesterol What You Need to Know. Age: 45 Women and Cholesterol: What You Need to Know HDL: 60 mg/dL and above LDL: Below 100 mg/dL GoodBad.
More Palatable Nutrition Guidelines Ron Krauss, MD Senior Scientist, Head of Molecular Medicine Lawrence Berkeley National Laboratory University of California.
The Lipids Triglycerides Phospholipids Sterols Copyright 2005 Wadsworth Group, a division of Thomson Learning.
Nutrition & Heart Disease Key Concepts and Facts Heart disease is leading cause of death Dietary and lifestyle factors are important Diets that provide.
ALPHA OMEGA: Effect of low doses of n-3 fatty acids on cardiovascular diseases in post-MI patients Daan Kromhout, MPH PhD for the Alpha Omega Trial Group.
Diet &Cardiovascular System
Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Trial MEGA Trial Presented at The American Heart Association.
Taipei Medical University. Adolescents with Higher Althernate Healthy Eating Index For Taiwan (AHEI-T) Scores Have Lower Blood Lipid Level De-Zhi Weng,
Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 2 ARBITER-2 Trial Presented at The American Heart Association Scientific.
Take the guesswork out of Nutrition!
This lecture was conducted during the Nephrology Unit Grand Ground by Nephrology Registrar under Nephrology Division, Department of Medicine in King Saud.
© 2006 Thomson-Wadsworth The Lipids Triglycerides Phospholipids Sterols.
Vocabulary Flashcards Chapter 7 - Nutrition & Your Fitness Go to first word…
Methodological Issues in Systematic Review - Formulating Questions - Joseph Lau, MD Tufts Medical Center EPC AHRQ Annual Meeting September 10, 2008.
Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Lutein + Zeaxanthin and Omega-3 Fatty Acids for Age-Related.
Data Sources Definitions
LOW CARB, HIGH FAT ECON 4 LIN THOMPSON. KETOGENIC DIETS < 100 CARBOHYDRATES PER DAY ADKINS IS THE BEST KNOWN KETOGENIC DIET PUTS THE BODY IN KETOSIS.
Chapter 09 9 Hyperlipidemia and Dyslipidemia C H A P T E R Grandjean, Gordon, Davis, and Durstine.
Eicosapentaenoic Acid Eicosapentaenoic acid Eicosapentaenoic acid (EPA) is an omega-3 fatty acid.
Chapter 7 - Nutrition & Your Fitness
Therapeutic Lifestyle
M.Sc. in Pharmacy/Clinical Laboratory Sciences
Krill oil supplementation lowers serum triglycerides without increasing low-density lipoprotein cholesterol in adults with borderline high or high triglyceride.
Copyright © 2017 American Academy of Pediatrics.
Omega 3
AIM HIGH Niacin plus Statin to prevent vascular events
Lipids in Health and Disease
Cardiovascular System
National Cholesterol Education Program
Classification of total cholesterol levels
What is the likely mechanism by which HDL-C reduces coronary heart disease?
Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment:
Lipids in Health and Disease
Omega-3 Prescriptions vs Supplements in Practice
Diabetes and Dyslipidemia
Back to the Basics of Dyslipidemia
Case Study: 45-year-old Man
Amarin Beyond LDL: Focused Insights High Triglycerides, Very High Triglycerides and CV Residual Risks December 2017.
Omega-3 Fatty Acids for Cardioprotection
Cardiovascular Disease
The Chemical Differences Between EPA and DHA.
Type 2 diabetes: Overlap of clinical conditions
PCSK9 Inhibitors and Cardiovascular Outcomes
Residual Risk After Statin Therapy:
Radical New Concepts in Lipid Management
1 2 The Good, Bad, Ugly and Deadly.
Advances in Hypertriglyceridemia Treatment
Lipids in Health and Disease
Chapter 7 LIPIDS IN HEALTH & DISEASE
Daan Kromhout, et al. NEJM epub August 29, 2010
Lipid Updates From Spring 2019
Goals & Guidelines A summary of international guidelines for CHD
Omega-3s vs Pure EPA in Clinical Practice
III. Treating dyslipidemias
Dyslipidemia And Diabetes
in diabetic patients with mixed dyslipidemia
Shared-Decision Making in Dyslipidemia
Presentation transcript:

The Chemical Differences Between EPA and DHA

Omega-3 Fatty Acid Intake AHA Recommendations

Prescription-only Omega-3s vs Dietary Supplement Omega-3s

Secondary Causes of Hypertriglyceridemia

TG Levels What Is Considered High?

Effects of Nutrition Practices on TG Lowering

2013 ACC/AHA Lipid Guidelines

Women’s Health Study Nonfasting vs Fasting Lipid Levels for Predicting Cardiovascular Events

Recommendations When Triglycerides  500 mg/dL

Post hoc Analysis of AIM-HIGH ERN in Patients With High TG and Low HDL Cholesterol Levels

Lipid Effects of Drug Classes in Dyslipidemia and Hypertriglyceridemia

Select Omega-3 Outcomes Studies

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.